"Digestive Research Alliance of Michiana facilitates clinical research trials in GI disease, concentrating largely on NASH and Fatty Liver Disease."

During the past decade, Digestive Research Alliance of Michiana, LLC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Digestive Research Alliance of Michiana, LLC" are "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials), "Fibrosis, Liver" (1 trials), "NAFLD" (1 trials) and "Nonalcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "Digestive Research Alliance of Michiana, LLC" in a lesser frequency.

Most popular intervention types in "Digestive Research Alliance of Michiana, LLC" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials), "Guselkumab Dose 3" (2 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Research Alliance of Michiana, LLC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Research Alliance of Michiana, LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Digestive Research Alliance of Michiana, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Research Alliance of Michiana, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".